中國醫藥學院 醫學系 學士 1976.09~1983.06

和信治癌中心醫院 放射腫瘤科 碩學主治醫師 1991.07~2022.06
和信治癌中心醫院 放射腫瘤科 主任1991.07~2022.06
和信治癌中心醫院 醫學研究部 第一副主任 2013.05~2017.12
和信治癌中心醫院 臨床研究室 主任 2009.03~2017.12
臺灣放射腫瘤醫學會 理事 2010~迄今
醫學雜誌論文審查委員International Journal of Radiation Oncology, Biology and Physics (美國) 審查委員2001~迄今
美國杜克大學醫學中心 放射腫瘤部 兼任副教授 2001~2010
中華民國乳房醫學會 理事會 副秘書長 2000~2007
醫學雜誌論文審查委員 Cancer(美國) 審查委員 2000~迄今
醫學雜誌論文審查委員 Journal of Clinical Oncology(美國) 審查委員 1998~迄今
中華民國癌症醫學會 理事會 理事 1997~2000 ; 常務理事2007~2011

台北市醫師公會會員
中華民國放射線醫學會會員
中華民國癌症醫學會會員
美國放射腫瘤學會會員
台灣放射腫瘤醫學會
台灣乳房醫學會

• Book Chapter, Skye H. Cheng and Andrew T. Huang. Chapter 60: Liver And Hepatobiliary Tract in Principles And Practice Of Radiation Oncology; Edited by Perez C, Brady L, Halperin E and Schmidt-Ullrich R. From 4th to 6th Edition, Lippincott Williams and Wilkins 2004-2012.
• Ming-Ta Hsu, Ching Cheng, Chian-Feng, Chen, Yiin-Jeng Jong, Chien-Yi Tung, Yann-Jang Chen, Sheng Wang-Wuu, Ling-Hui Li, Shih-Feng Tsai, Mei-Hua Tsou, Skye H. Cheng, Chii-Ming Chen, Andrew T. Huang, Chi-Hung Lin. Comparison of Genome Aberrations Between Early-Onset and Late-Onset Breast Cancer. 12/2011; ISBN: 978-953-307-730-7.
• Publications, Zen (Cheng) SH*, Jame JM, Chang AYC, Li WY, Law CK, Chen KY, Lin CZ. Nasopharyngeal carcinoma with bone marrow metastasis. American Journal of Clinical Oncology; 14: 66-70, 1991. (SCI).
• Chang AYC*, Su SWC, Zen (Cheng) SH, Wang WCC. Nasopharyngeal carcinoma in patients thirty years or younger. American Journal of Clinical Oncology; 14: 1-4, 1991. (SCI).
• Cheng SH*, Jian JM, Chen CM, Huang AT. Breast-Preserving Therapy for Early Breast Cancer: A Preliminary Report and a Review of Literature. J. Chinese Oncol. Soc. 9: 8-21, 1993.
• Lin YM*, Liu TW, Lin HH, Chen CM, Cheng SH, Huang AT, Sung JL. Endoscopic Features of Duodenal Metastases from Breast Cancer. Dig. Endosc. 6: 281-286,1994. (SCI).
• Kok V.* CK, Huang AT, Lin HH, Cheng SH. Metastatic Renal Cell Carcinoma with Protracted Course Masquerading Thyroid Carcinoma. J. Chinese Oncol. Soc. 10:195-201, 1994.
• Cheng SH*, Jian JM, Huang AT. Comments on Radiotherapy for Nasopharyngeal Carcinoma: Shielding the Pituitary May Improve Therapeutic Ratio. Int J Radiation Oncol Biol Phys 31:682-4, 1995. (SCI).
• Cheng SH*, Kang SS, Chen CM, Huang PH, Chan JK, Jian JM. Dose Uniformity for the Triangle Between Tangential Fields and Internal Mammary Field in Breast Preservation Therapy. Chinese J. Radiology 20: 53-62, 1995.
• Cheng SH*, Chan WP, Lin YM, Liu MC, Chan KY, Jian JM. Magnetic Resonance Imaging in the Determination of Radiation Treatment Volume in Esophageal Carcinoma. J. Chinese Oncol. Soc. 11: 25-32, 1995.
• Lei Lei1, Xiao-Jia Wang1, Yin-Yuan Mo2, Nei-Min Chu3, Ben-Long Yu4, Skye Hung-Chun Cheng*,5, Yunyun Zhou*,6 DGM-CM6: a new model to predict prognosis for breast cancer based on clinical and genomic signatures. Scientific Reports 2020; 10: 22223.
• Hung-Chun Cheng Skye*, Wen-Chun Hung, Chia-Hsien Lin, Ming-Chuan Hsu, Ya-Li Tsai, Yan-Shen Shan, Tsung-Yen Cheng, Li-Tzong Chen. Integrated Transcriptomic and Methylomic Analysis Identifies a METTL7A-Driven Epigenomic Network Associated with Early-Stage Pancreatic Cancer. Journal of Translational Medicine 2020; 18:312.
• Huang TT, Cheng SH*, Horng CF, Yu BL, Tsai SY, Lin YP, Jian JJM, Chen HH, Tsou MH, Chu NM, Liu MC, Huang AT. Personalized Prediction of Distant Metastasis in Breast Cancer: Integration of Clinical and Genomic Data Using a Clinical–Genomic Model. Int J Radiat Oncol Biol Phys. 2020;106(3):538-546.
• Huang C-C, Chan S-Y, Lee W-C, Chiang C-J, Lu T-P, Cheng SH-C. External validation of a prediction model for breast cancer based on the national cancer registry in Taiwan. Breast Cancer Research 2021; 23(1): 1.
• Cheng SH*, Yu BL, Tsai SY, Horng CF, Chen CM, Jian JJM, Chu NM, Tsou MH, Liu MC, Huang AT. Validation of AJCC 8th Edition Staging for Breast Cancer in Taiwan Using National Cancer Registry. J Cancer Research and Practice 2021; 38(1): 19-27.
• Yang PS, Lee YH, Tsai Y-C, Hung-Chun Cheng S*, Huang CC, Huang TT. Clinical validation of an 18-gene classifier-based predictive model compared with the Oncotype DX 21-gene assay for breast cancer recurrence. NPJ Breast Cancer. 2021;7(1):14.
• Chuang W-K, Cheng C-T, Tsai Y-C, Lim L-C, Lin Y-P, Cheng S.H-C*. Postmastectomy radiotherapy for breast cancer patients with N1 disease: Updated analysis using national cancer registry data. Journal of Cancer Research and Practice 2022; 39(1): 12–19.
• Wu JS, Tsai Y-C, Jian JJ-M, Chen H-H, Horng C-F, Cheng SH-C*. Risk Stratification and De-escalation Strategy for Adjuvant Therapy in Nasopharyngeal Carcinoma Using a Clinical-Genomic Model. Radiation Oncology 2022; 17(1): 1-10.
• Huang C-C, Chan S-Y, Lee W-C, Chiang C-J, Lu T-P, Cheng SH-C*. A Web-based Risk Prediction Model for Breast Cancer Using Taiwan''s National Registry. Breast Cancer Research and Treatment. 2023; 190(2): 399–411.
• Huang C-C, Lee W-C, Chan S-Y, Chiang C-J, Lu T-P, Cheng SH-C*. Development and validation of a multi-omics integrated risk prediction model for breast cancer recurrence in Taiwan. BMC Cancer. 2023; 23: 541.
• Tsai Y-C, Huang C-C, Lee W-C, Lu T-P, Cheng SH-C*. Machine learning-based prognostic model for breast cancer survival prediction using clinical and genomic data. Scientific Reports. 2024; 14: 8932.
• Lee W-C, Huang C-C, Chan S-Y, Cheng SH-C*. Comprehensive genomic profiling and its clinical implications in breast cancer patients in Taiwan. Frontiers in Oncology. 2024; 14: 1122.
• Cheng SH-C*, Lin Y-P, Huang TT, Horng CF. Integrative analysis of transcriptomic and methylomic profiles identifies novel biomarkers for early detection of breast cancer. Journal of Biomedical Science. 2024; 31(1): 45.
• Huang C-C, Lee W-C, Chan S-Y, Tsai Y-C, Cheng SH-C*. External validation and clinical utility of a web-based prognostic tool for breast cancer recurrence. Cancer Medicine. 2025; 14(2): 770-782.
• Tsai Y-C, Huang C-C, Lee W-C, Cheng SH-C*. Predicting response to neoadjuvant chemotherapy in breast cancer patients using a clinical-genomic model. npj Breast Cancer. 2025; 11(1): 12.